Ms. Abraham-Freel joined Diagnostics For All (DFA) in December 2014 as the manager of Quality Management Systems (QMS). She has over 20 years of relevant experience in Quality System Regulations, Design Controls and Good Manufacturing Practices (GMPs) in Product Development, Manufacturing Operations and Clinical & Regulatory Affairs for medical devices, pharmaceuticals and biologics. She is proficient in all phases of product life cycle development for medical devices, from design concept through commercialization, including technology transfer. She also has nine patents in the US and several publications for her previous work in product development at Organogenesis, Inc. Ginger holds a Bachelor of Science degree in Biology and Chemistry from Stonehill College
Assistant to the CFO
KC joined Diagnostics For All in August 2015. She has a B.A. in Public Health from Brown University and is interested in global health and international development. Prior to joining DFA, KC worked on digital strategy for Article 25, a global health advocacy group based in Boston, MA.
W. Matthew Dickerson
Dr. W. Matthew Dickerson joined DFA in May of 2015 as a Senior Scientist. Dr. Dickerson has more than 20 years of experience in the development and optimization of biological assays in the pharmaceutical industry. Previous to joining DFA he was a senior scientist and head of collaborations at BioScale Inc. At BioScale, he was one of the chief architects for the design and development of assays utilizing the AMMP technology for bioanalytical, preclinical and clinical development. His work includes assays for cytokines, inflammatory biomarkers, phosphoproteins, anti-drug antibodies and cell-based assays. Prior to BioScale, Dr. Dickerson was a senior scientist at ILEX Oncology where he focused on the production and development of antibodies for therapeutic development. He has also developed cell-based screening assay for cancer therapeutics which included Tumistatin and Mucin-1. Dr. Dickerson had similar positions at both Genetics Institute and Biotransplant. Dr. Dickerson received his BS in biology at Mary Washington College and PhD in pharmacology at Northeastern University. He has been an invited speaker at major industry conferences and has multiple publications in peer-reviewed journals.
Chief Executive Officer
Marcus is the CEO of Diagnostics For All. Prior to this, Marcus has directly founded and run businesses in environmental services, real estate, utility metering technology, and broadband wireless. Most recently he ran Sensable Technologies (haptics and 3D software) and Microbia Inc (industrial biotechnology). He has an MA in chemistry from Oxford and the Gibbs Prize in Chemistry.
Kendall grew up in New Hampshire and graduated from the University of New Hampshire in May 2014 with a B.S. in Biomedical Science. Her undergraduate research involved conducting a mutant screen in the Hrabak lab, where she selected and characterized mutant Arabidopsis thaliana plants with novel root growth to better understand signaling during plant root growth. Kendall has also worked as a veterinary technician at an equine veterinary practice.
Technical Project Coordinator
Lae joined Diagnostics for All in April 2015. She has a B.A. in International Studies from Bentley University. Prior to joining DFA, Lae held various positions ranging from administration to finance at Ascion, LLC.
Intern for Liver Function
Vivian Ramirez joined Diagnostics for All in September 2015 as an intern. She is currently a Senior at Boston University studying Biomedical Engineering with a Concentration in Technology Innovation. As an Inspiration Ambassador, she mentors high school robotics teams and makes outreach visits to inspire the next generation of engineers. She is involved in Engineering Student Government as the Executive Board Secretary, a member of Theta Tau Professional Engineering Fraternity, and a volunteer with Mustard Seed Communities.
Michelle Wong joined DFA in May 2014 as a Research Associate. Prior to joining DFA, she was a Research Assistant for the Cabodi Research Group at Boston University. The focus of her research was a platform for microfluidic sample preparation, for eventual point-of-care use, as well as the development of its commercial prototype. She graduated from Boston University with a B.S. in Biomedical Engineering.
Sign up here to receive updates from DFA on our projects, our products, and our journeys. Small products; big change.